Solventum Corp 10-Q

Item 4. Controls and Procedures Evaluation of Disclosure Controls and Processes The Company carried out an evaluation, under the supervision and with the participation of its management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in the Exchange Act Rule 13a-15(e)) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective. Changes in Internal Controls Over Financial Reporting There was no change in the Company’s internal control over financial reporting that occurred during the Company’s most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. 35 Table of Contents SOLVENTUM CORPORATION FORM 10-Q For the Quarterly Period Ended March 31, 2025 PART II. Other Information Item 1. Legal Proceedings Discussion of legal matters is incorporated by reference from Part I, Item 1, Note 12, “ Commitments and Contingencies, ” of this document, and should be considered an integral part of Part II, Item 1, “ Legal Proceedings. ” Item 1A. Risk Factors There have been no material changes to the risk factors as disclosed in our 2024 Annual Report on Form 10-K. Discussion of these factors is incorporated by reference into and considered an integral part of Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Item 2. Unregistered Sales of Equity Securities and Use of Proceeds There were no unregistered sales of equity securities during the period covered by this report. Item 3. Defaults Upon Senior Securities No matters require disclosure. Item 4. Mine Safety Disclosures Not applicable.